Brain changes during the onset of schizophrenia: Implications for neurodevelopmental theories

Medical Journal of Australia

Volumn 190, Issue 4 SUPPL., 2009, Pages

  Wood, Stephen J ^a   Pantelis, Christos ^a   Yung, Alison R ^a   Velakoulis, Dennis ^a   McGorry, Patrick D ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; BRAIN DEVELOPMENT; BRAIN SIZE; CANNABIS SMOKING; DISEASE EXACERBATION; HIGH RISK POPULATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NERVOUS SYSTEM DEVELOPMENT; NEUROIMAGING; NONHUMAN; ONSET AGE; PREFRONTAL CORTEX; PSYCHOSIS; SCHIZOPHRENIA; TEMPORAL LOBE; THALAMUS;

EID: 61849155130     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2009.tb02367.x     Document Type: Article

References (42)

1. Olsen KA, Rosenbaum B. Prospective investigations of the prodromal state of schizophrenia: review of studies. Acta Psych iatr Scand 2006; 113: 247-272.
2. Yung AR. Identification and treatment of the prodromal phase of psychotic disorders: perspectives from the PACE Clinic. Early Interv Psychiatry 2007; 1: 224-235.
3. Whalley HC, Harris JC, Lawrie SM. The neurobiological underpinnings of risk and conversion in relatives of patients with schizophrenia. Int Rev Psychiatry 2007; 19: 383-397.
4. Wood SJ, Pantelis C, Velakoulis D, et al. Progressive changes in the development toward schizophrenia: studies in subjects at increased symptomatic risk. Schizophr Bull 2008; 34: 322-329.
5. Lawrie SM, McIntosh AM, Hall J, et al. Brain structure and function changes during the development of schizophrenia: the evidence from studies of subjects at increased genetic risk. Schizophr Bull 2008; 34: 330-340.
6. Weinberger DR, Marenco S. Schizophrenia as a neurodevelopmental disorder. In: Hirsch SR, Weinberger DR, editors. Schizophrenia. Oxford: Blackwell Science, 2003: 326-348.
7. Shenton ME, Dickey CC, Frumin M, McCarley RW. A review of MRI findings in schizophrenia. Schizophr Res 2001; 49: 1-52.
8. Borgwardt SJ, Riecher-Rossler A, Dazzan F, et al. Regional gray matter volume abnormalities in the at risk mental state. Biol Psychiatry 2007; 61: 1148-1156.
9. Pantelis C, Velakoulis D, McGorry PD, et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI study. Lancet 2003, 361: 281-288.
10. Harris JM, Moorhead W, Miller P, et al. Increased prefrontal gyrification in a large high-risk cohort characterizes those who develop schizophrenia and reflects abnormal prefrontal development. Biol Psychiatry 2007; 62: 722-729.
11. Walterfang M, McGuire PK, Yung AR, et al. White matter volume changes in people who develop psychosis. Br J Psychiatry 2008; 193: 210-215.
12. Job DE, Whalley H, Johnstone EC, Lawrie SM. Grey matter changes over time in high risk subjects developing schizophrenia. Neuroimage 2005; 25: 1023-1030.
13. Crum WR, Griffin LD, Hill DLG, Hawkes DJ. Zen and the art of medical image registration: correspondence, homology, and quality. Neuroimage 2003; 20: 1425-1437.
14. Sun D, Phillips LJ, Velakoulis D, et al. Progressive brain structural changes mapped as psychosis develops in "at risk" individuals. Schizophr Res 2009; Jan 10 [Epub ahead of print].
15. Gogtay N, Giedd JN, Lusk L, et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A 2004; 101: 8174-8179.
16. Takahashi T, Wood SJ, Yung AR, et al. Progressive grey matter reduction of the superior temporal gyrus during transition to psychosis. Arch Gen Psychiatry. In press.
17. Barta PE, Pearlson GD, Powers RE, et al. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am J Psychiatry 1990; 147: 1457-1462.
18. Takahashi T, Suzuki M, Zhou S-Y, et al. Morphologic alterations of the parcellated superior temporal gyrus in schizophrenia spectrum. Schizophr Res 2006; 83: 131-143.
19. Hillman CH, Erickson KI, Kramer AF. Be smart, exercise your heart: exercise effects on brain and cognition. Nat Rev Neurosci 2008; 9: 58-65.
20. Ilg R, Wohlschläger AM, Gaser C, et al. Gray matter increase induced by practice correlates with task-specific activation: a combined functional and morphometric magnetic resonance imaging study. J Neurosci 2008; 28: 4210-4215.
21. Phillips LJ, McGorry PD, Garner B, et al. Stress, the hippocampus and the hypothalamic-pituitary-adrenal axis: implications for the development of psychotic disorders. Aust N Z J Psychiatry 2006; 40: 725-741.
22. Bremner JD. Does stress damage the brain? Biol Psychiatry 1999; 45: 797-805.
23. Thompson KN, Phillips LJ, Komesaroff F, et al. Stress and HPA-axis functioning in young people at ultra high risk for psychosis. J Psychiatr Res 2007; 41: 561-569.
24. Garner B, Pariante CM, Wood SJ, et al. Pituitary volume predicts future transition to psychosis in individuals at ultra-high-risk of developing psychosis. Biol Psychiatry 2005; 58: 417-423.
25. Rais M, Cahn W, van Haren NEM, et al. Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients. Am J Psychiatry 2008; 165: 490-496.
26. Phillips LJ, Curry C, Yung AR, et al. Cannabis use is not associated with the development of psychosis in an "ultra" high-risk group. Aust N Z J Psychiatry 2002; 36: 800-806.
27. Konopaske GT, Dorph-Petersen KA, Pierri JN, et al. Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys. Neuropsychopharmacology 2007; 32: 1216-1223.
28. Dorph-Petersen KA, Pierri JN, Perel JM, et al. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology 2005; 30: 1649-1661.
29. Garver DL, Holcomb JA, Christensen JD. Cerebral cortical gray expansion associated with two second-generation antipsychotics. Biol Psychiatry 2005; 58: 62-66.
30. Lieberman JA, Tollefson G, Charles C, et al. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry 2005; 62: 361-370.
31. McClure RK, Carew K, Greeter S, et al. Absence of regional brain volume change in schizophrenia associated with short-term atypical antipsychotic treatment. Schizophr Res 2008; 98: 29-39.
32. Nesväg R, Lawyer G, Varnäs K, et al. Regional thinning of the cerebral cortex in schizophrenia: effects of diagnosis, age and antipsychotic medication. Schizophr Res 2008; 98: 16-28.
33. Vidal C, Rapoport JL, Hayashi KM, et al. Dynamically spreading frontal and cingulate deficits mapped in adolescents with schizophrenia. Arch Gen Psychiatry 2006; 63: 25-34.
34. Walterfang M, McGuire PK, Yung AR, et al. White matter volume changes in people who develop psychosis. Br J Psychiatry 2008; 193: 210-215.
35. Job DE, Whalley HC, McIntosh AM, et al. Grey matter changes can improve the prediction of schizophrenia in subjects at high risk. BMC Med 2006; 4: 29.
36. Pantelis C, Yücel M, Wood SJ, et al. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr Bull 2005; 31: 672-696.
37. DeLisi LE. The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia. Schizophr Bull 2008; 34: 312-321.
38. Paus T. Mapping brain maturation and cognitive development during adolescence. Trends Cogn Sci 2005; 9: 60-68.
39. Yung AR, Killacky E, Hetrick SE, et al. The prevention of schizophrenia. Int Rev Psychiatry 2007; 19: 633-646.
40. Wellard RM, Briellman RS, Jennings C, Jackson GD. Physiologic variability of single-voxel proton MR spectroscopic measurements at 3T. AJNR Am J Neuroradiol 2005; 26: 585-590.
41. 1H PRESS at 4.0T: precision and variability of measurements in anterior cingulate and hippocampus. NMR Biomed 2006; 19: 484-491.
42. Yücel M, Lubman DI, Harrison BJ, et al. A combined spectroscopic and functional MRI investigation of the dorsal anterior cingulate region in opiate addiction. Mol Psychiatry 2007; 12: 691-702.